Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus

This study has been completed.
Sponsor:
Collaborators:
Juvenile Diabetes Research Foundation
American Diabetes Association
Information provided by (Responsible Party):
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00505375
First received: July 20, 2007
Last updated: December 17, 2013
Last verified: December 2013